论文信息 - Planning for COVID-19 vaccines safety surveillance - 字舞流文

Planning for COVID-19 vaccines safety surveillance

S. Kochhar | D. Salmon

[1] Robert T. Chen,et al. The Brighton Collaboration standardized templates for collection of key information for benefit-risk assessment of vaccines by technology (BRAVATO; formerly V3SWG) , 2020, Vaccine.

[2] Robert T. Chen,et al. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines , 2020, Vaccine.

[3] Robert T. Chen,et al. Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines , 2020, Vaccine.

[4] Barney S. Graham,et al. Rapid COVID-19 vaccine development , 2020, Science.

[5] Edith Jasny,et al. New Vaccine Technologies to Combat Outbreak Situations , 2018, Front. Immunol..

[6] Aysha Akhtar,et al. Immunization-Safety Monitoring Systems for the 2009 H1N1 Monovalent Influenza Vaccination Program , 2011, Pediatrics.

[7] Shibo Jiang,et al. The spike protein of SARS-CoV — a target for vaccine and therapeutic development , 2009, Nature Reviews Microbiology.